Traws Pharma, Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
TRAW on Nasdaq
Industry
Pharmaceutical Preparations
Location
12 Penns Trail, Newtown, PA

There are no Buy or Sell transactions made by insiders since 10/7/2024

Traws Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Viriom, Inc. 10%+ Owner $1.48M Apr 3, 2024
Orbimed Advisors Llc 10%+ Owner $283K Dec 29, 2024
Steven M. Fruchtman PRESIDENT, CHIEF EXECUTIVE OFF, Director $98.3K Mar 13, 2024
Charles David Pauza Chief Science Officer Virology $87.8K Apr 1, 2024
Robert Redfield Acting Chief Medical Officer $87.8K Apr 1, 2024
Iain Dukes Executive Chairman, Director $63.1K Apr 1, 2024
Nikolay Savchuk Chief Operating Officer, Director, 10%+ Owner $63.1K Dec 29, 2024
Abraham N. Oler SVP Corp Dev & Gen Counsel $36.8K Feb 7, 2022
Mark S. MD Gelder Chief Medical Officer $24.5K Mar 13, 2023
Mark Patrick Guerin Chief Financial Officer $23.4K Feb 5, 2025
Werner Cautreels Director $1.04K Jun 19, 2025
Tpav, Llc 10%+ Owner $0 Apr 2, 2025
Viren Mehta Director Aug 10, 2023
Victor M. Moyo Chief Medical Officer Oct 2, 2023
Jerome Groopman Director Aug 10, 2023
James J. Marino Director Aug 10, 2023
Peter Atadja Director Aug 10, 2023
Mary Teresa Shoemaker Director Jun 19, 2025
Jack E. Stover Director Jun 19, 2025
Nora Brennan Interim CFO Feb 5, 2025
Trafford Clarke Director Jun 19, 2025
Luba Greenwood Director Sep 16, 2024

Recent Insider Transactions by Companies or Individuals for Traws Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.